ScholarLens Back to search
2001•Shengming kexueRequires access

The progress of retroviral vector in hemophilia A gene therapy

Mei Wen

Open publisher page 0 citations

Abstract

Gene therapy is the best method to approach the complete cure of hemophilia A. Retrovirus is one of the vectors in common use. Here, we review the advance in the research of retroviral vector in the hemophilia A gene therapy.

About this research paper

What this paper is about

Gene therapy is the best method to approach the complete cure of hemophilia A. Retrovirus is one of the vectors in common use. Here, we review the advance in the research of retroviral vector in the hemophilia A gene therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Gene therapy is the best method to approach the complete cure of hemophilia A. Retrovirus is one of the vectors in common use. Here, we review the advance in the research of retroviral vector in the hemophilia A gene therapy.

Key concepts: Retrovirus, Genetic enhancement, Vector (molecular biology), Viral vector, Virology, Vectors in gene therapy, Gene, Gene transfer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The progress of retroviral vector in hemophilia A gene therapy — Research Paper | ScholarLens